Now that the VISION trial of Lu-177-PSMA-617 is no longer recruiting, some patients are wondering if they can still get PSMA-targeted radiopharmaceuticals in the US, without traveling to Germany, Australia, India, etc. Here is a list of trials that are active, still open to recruitment, or will soon be recruiting.
Unless otherwise noted, they are all for men who are:
- metastatic
- castration-resistant
- have had at least one taxane chemotherapy
- at least one of the advanced androgen receptor therapies (e.g., Zytiga, Xtandi, Erleada, or Nubeqa)
- no Xofigo
- PSMA-avid on a PSMA PET/CT scan
Links that have contact information are provided.
 |
I spoke with MSK in NY today 8/28/20. They are offering an observational study, not specifically a clinical trial. NCT #04030338. Using Ga68 as a diagnostic tool; not for treatment purposes. Not likely covered by insurance. Cost approx $7,500. Need at least two consecutive PSA tests reflecting minimum 0.2 within last 6 mos.
ReplyDelete